Ongoing investigations into the drug are demonstrating exciting potential beyond its initial indication for type 2 condition. Researchers are actively examining the manner in which this GLP-1 receptor agonist impacts body composition, cardiovascular function, and potentially brain health. These findings point to a wide array of future treatments, f